Kyverna Therapeutics, Inc. (KYTX)
USD 3.79
(-9.55%)
USD 3.79
(-9.55%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -52.41 Million | -36.11 Million | -22.15 Million |
| Net Income | -60.36 Million | -28.89 Million | -26.35 Million |
| Depreciation & Amortization | 1.7 Million | 1.05 Million | 586 Thousand |
| Deferred income taxes | - | - | - |
| Stock-based compensation | 2.22 Million | 929 Thousand | 7.25 Million |
| Change in working capital | 3.42 Million | -10.32 Million | -4.49 Million |
| Other non-cash items | 1.72 Million | 1.41 Million | 829 Thousand |
| Investing Cash Flow | -8.78 Million | -14.09 Million | -1.28 Million |
| Investments in PPE | -621 Thousand | -768 Thousand | -1.28 Million |
| Acquisitions | - | - | - |
| Investment purchases | -54.84 Million | -56.49 Million | - |
| Sales/Maturities of investments | 46.68 Million | 43.16 Million | - |
| Other Investing Activities | -8.16 Million | -13.32 Million | - |
| Financing Cash Flow | 58.11 Million | 11.88 Million | 72.52 Million |
| Debt repayment | -781 Thousand | -249 Thousand | -41 Thousand |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 58.89 Million | 12.12 Million | 72.56 Million |
| Other Financing Activities | -1.64 Million | 12.12 Million | 72.56 Million |
| Accounts receivables | - | - | - |
| Accounts payables | 4.08 Million | 677 Thousand | 11 Thousand |
| Inventory | - | - | - |
| Other working capital | -659 Thousand | -7.02 Million | -5.65 Million |
| Cash at beginning of period | 38.28 Million | 76.61 Million | 27.54 Million |
| Cash at end of period | 35.21 Million | 38.28 Million | 76.61 Million |
| Capital Expenditure | -621 Thousand | -768 Thousand | -1.28 Million |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | -3.07 Million | -38.33 Million | 49.07 Million |
| Free Cash Flow | -53.03 Million | -36.88 Million | -23.44 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -28.8 Million | -26.69 Million | -20.66 Million | -60.36 Million | -15.46 Million | -13.09 Million |
| Depreciation & Amortization | 530 Thousand | 482 Thousand | 462 Thousand | 1.7 Million | 438 Thousand | 413 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.28 Million | 2.27 Million | 784 Thousand | 2.22 Million | 521 Thousand | 447 Thousand |
| Change in working capital | 4.4 Million | -1.83 Million | 1 Million | 3.42 Million | 3.37 Million | 528 Thousand |
| Other non-cash items | 2.85 Million | 526 Thousand | 454 Thousand | 1.72 Million | 892 Thousand | 438 Thousand |
| Investing Cash Flow | -67.92 Million | -122.87 Million | 31.68 Million | -8.78 Million | -54.11 Million | -3000.00 |
| Investments in PPE | -1.02 Million | -543 Thousand | -334 Thousand | -621 Thousand | -256 Thousand | -3000.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -79.89 Million | -145.33 Million | -985 Thousand | -54.84 Million | -53.86 Million | - |
| Sales/Maturities of investments | 13 Million | 23 Million | 33 Million | 46.68 Million | - | - |
| Other Investing Activities | - | -122.33 Million | 32.01 Million | -8.16 Million | - | - |
| Financing Cash Flow | -569 Thousand | 338.04 Million | -1.43 Million | 58.11 Million | 34.79 Million | 24.9 Million |
| Debt repayment | -236 Thousand | -231 Thousand | -219 Thousand | -781 Thousand | -205 Thousand | -189 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -333 Thousand | 341.17 Million | -1.37 Million | 58.89 Million | 35.15 Million | - |
| Other Financing Activities | -406 Thousand | -2.95 Million | -1.49 Million | -1.64 Million | -156 Thousand | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.1 Million | 3.06 Million | 2.97 Million | 4.08 Million | 509 Thousand | 490 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.5 Million | -4.9 Million | -1.97 Million | -659 Thousand | 2.86 Million | - |
| Cash at beginning of period | 224.28 Million | 35.21 Million | 23.52 Million | 38.28 Million | 53.98 Million | 40.34 Million |
| Cash at end of period | 131.61 Million | 224.85 Million | 35.21 Million | 35.21 Million | 23.52 Million | 53.98 Million |
| Capital Expenditure | -1.02 Million | -543 Thousand | -334 Thousand | -621 Thousand | -256 Thousand | -3000.00 |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -92.66 Million | 189.64 Million | 11.68 Million | -3.07 Million | -30.46 Million | 13.64 Million |
| Free Cash Flow | -25.2 Million | -26.06 Million | -18.89 Million | -53.03 Million | -11.38 Million | -11.26 Million |
CARTRADE
MTS
AIA
277810
1742
AUTOIND